Trial Profile
Clinical Trials Insight: 700038427
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Aug 2012
Price :
$35
*
At a glance
- Drugs EGb 761 (Primary)
- Indications Alzheimer's disease; Vascular dementia
- Focus Therapeutic Use
- Sponsors Dr. Willmar Schwabe Pharmaceuticals
- 29 Oct 2008 New trial record.